Showing results (181-190 of 365) with videos related to
Sort By:
Pageof 37
Cancer Treatment and Research Communications|December 25, 2024
Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classificationYoungkyung Jeon, Ji-Yeon Kim, Jin Seok Ahn, et al.Frontiers in Oncology|May 21, 2021
Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center RegistryJi-Yeon Kim, Yong Seok Lee, Jonghan Yu, et al.Cancer Chemotherapy and Pharmacology|June 17, 2008
Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?Byeong-Bae Park, Ji Eun Uhm, Eun Yoon Cho, et al.BMC Cancer|May 24, 2024
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancerSherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, et al.Cancer Research and Treatment|September 5, 2018
Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry DataEun Kyoung Kim, Jinhyun Cho, Ji-Yeon Kim, et al.Nature Communications|May 6, 2017
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancerWoosung Chung, Hye Hyeon Eum, Hae-Ock Lee, et al.International Journal of Cancer|December 25, 2014
A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgeryYeon Hee Park, Hae Hyun Jung, In-Gu Do, et al.Clinical Breast Cancer|May 14, 2018
Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and TreatmentWon Kyung Cho, Doo Ho Choi, Won Park, et al.Clinical Breast Cancer|July 20, 2015
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard TreatmentsJeong Il Yu, Won Park, Doo Ho Choi, et al.Clinical Breast Cancer|May 11, 2015
Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic ManagementJeong Il Yu, Won Park, Doo Ho Choi, et al.Pageof 37